ClinicalTrials.gg
Sign In

Pigmentation Disorders clinical trials

The registry lists 57 studies for Pigmentation Disorders across more than 10 countries. 12 are recruiting or about to start. 32 of them are mainly about Pigmentation Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 7 narrower conditions too, such as Vitiligo: 714 studies, 182 open.

Get an email when these change. Save the Pigmentation Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
33
Recruiting
9
Active, not recruiting
4
Status unknown
4
Terminated
2
Withdrawn
2

Phase

Phase 2
9
Phase 4
4
Phase 1
3
Phase 3
1
Early Phase 1
1

Where

United States
25
China
3
Canada
3
India
3
France
3
Thailand
3

Who runs them

NovoBliss Research Pvt Ltd (3) · University of California, Davis (3) · Syneron Medical (3) · Chulalongkorn University (2) · Centre Hospitalier Universitaire de Nice (2) · Integrative Skin Science and Research (2) · University of Texas Southwestern Medical Center (2) · Netherlands Institute for Pigment Disorders (2)

What is being tested here

Drugs under test in Pigmentation Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bimatoprost101
Melatonin001
Ruxolitinib001
Tildrakizumab001
Cholecalciferol001
Glutathione001
Imiquimod001
Tacrolimus011
Bleomycin001

Coming up

0phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 9 Pigmentation Disorders studies recruiting now, 4 (44%) set no upper age limit and 4 (44%) stop at 75 or younger. 1 (11%) take children under 18. 1 (11%) are for women only and 0 (0%) for men only; 3 (33%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
101 (11%)1 (11%)
188 (89%)7 (78%)
308 (89%)7 (78%)
408 (89%)7 (78%)
508 (89%)7 (78%)
657 (78%)6 (67%)
755 (56%)4 (44%)
854 (44%)3 (33%)

Across all 57 studies, recruiting or not: 49% stop at 75 or younger and 46% at 65; 16% take children; 11% are for women only and 2% for men only; 49% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pigmentation Disorders studies take

Of 21 interventional studies with no phase under Pigmentation Disorders, half reached primary completion within 5 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase5 mo2–10 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 57. Browse all 57 → or search them.